Who makes NPC-15 Granules Higher Dose?

NPC-15 Granules Higher Dose is developed by Nobelpharma.

What development phase is NPC-15 Granules Higher Dose in?

NPC-15 Granules Higher Dose is in Phase 2.

Last reviewed 2026-04-19 · How we verify

NPC-15 Granules Higher Dose

Nobelpharma · Phase 2 active Small molecule

At a glance

Generic name	NPC-15 Granules Higher Dose
Also known as	Melatonin 4mg
Sponsor	Nobelpharma
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders (PHASE2, PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

NPC-15 Granules Higher Dose CI brief — competitive landscape report
NPC-15 Granules Higher Dose updates RSS · CI watch RSS
Nobelpharma portfolio CI